SCHEMBL17011937

SCHEMBL17011937

CN(C)S(=O)(=O)c1c(Cl)ccc(Nc2cc(=O)c2=O)c1O

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CCR6 P51684 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15434985 0.88 CXCR2 (0.54) CCR6
SCHEMBL20721141 0.78 CCR6 (1.00) CCR6
SCHEMBL14895291 0.78 CCR6 (0.69) CCR6
SCHEMBL20721308 0.76 CCR6 (1.00) CCR6
SCHEMBL20721132 0.75 CCR6 (1.00) CCR6
SCHEMBL20721270 0.75 CCR6 (1.00) CCR6
SCHEMBL1706737 0.75 CCR6 (0.68) CCR6
SCHEMBL20721275 0.74 CCR6 (1.00) CCR6
SCHEMBL20721258 0.74 CCR6 (1.00) CCR6
SCHEMBL20721212 0.74 CCR6 (1.00) CCR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2771334-B1 DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES GALDERMA RES & DEV (FR) 2015-08-19 — — EP disclosed
Send feedback